Levalbuterol Solution
Product Images NDC 35573-445

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 35573-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Burel Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Levalbuterol Inhalation Solution 1)

FDA Label Image

Figure D (Levalbuterol Inhalation Solution 10)

FDA Label Image

Figure E1 (Levalbuterol Inhalation Solution 11)

Figure E1 (Levalbuterol Inhalation Solution 11)
This text is a single word and does not provide enough information for a useful description. It appears to be referring to a "mouthpiece," which could be used in a variety of contexts such as music, sports, or medical equipment. Without further context, it is impossible to provide a specific description.*
FDA Label Image

Figure E2 (Levalbuterol Inhalation Solution 12)

FDA Label Image

Figure F (Levalbuterol Inhalation Solution 13)

FDA Label Image

Figure G1 (Levalbuterol Inhalation Solution 14)

FDA Label Image

Figure G2 (Levalbuterol Inhalation Solution 15)

FDA Label Image

Logo (Levalbuterol Inhalation Solution 16)

FDA Label Image

Carton (Levalbuterol Inhalation Solution 17)

FDA Label Image

Carton (Levalbuterol Inhalation Solution 18)

Carton (Levalbuterol Inhalation Solution 18)
This is a description of a medication called "Levalbuterol Inhalation Solution, USP". The text also includes some dosage instructions and packaging information.*
FDA Label Image

Carton (Levalbuterol Inhalation Solution 19)

FDA Label Image

Figure 1 (Levalbuterol Inhalation Solution 2)

Figure 1 (Levalbuterol Inhalation Solution 2)
This appears to be a chart or graph showing the mean change in FEV (forced expiratory volume, a measure of lung function) over time for four groups: Lev 1.2 with 65 participants, Lev 0.63 with 67 participants, Rac 25 with 70 participants, and PBO (placebo) with 70 participants. The percentage of change in FEV is given as the y-axis, and time in hours is given as the x-axis.*
FDA Label Image

Figure 2 (Levalbuterol Inhalation Solution 3)

Figure 2 (Levalbuterol Inhalation Solution 3)
This data presents the mean change in FEV (%) over time (hours) for different treatments: Lev1.25, Lev0.63, Rac 25, and PBO, with corresponding sample sizes (n=57, n=63, n=65, and n=63, respectively). The values in the table representing the percentage range from 0 to 35.*
FDA Label Image

Figure 3 (Levalbuterol Inhalation Solution 4)

FDA Label Image

Figure 4 (Levalbuterol Inhalation Solution 5)

FDA Label Image

Logo (Levalbuterol Inhalation Solution 6)

FDA Label Image

Figure A (Levalbuterol Inhalation Solution 7)

FDA Label Image

Figure B (Levalbuterol Inhalation Solution 8)

FDA Label Image

Figure C (Levalbuterol Inhalation Solution 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.